Return On Equity of Tempest Therapeutics, Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tempest Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Tempest Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -311%, a 66% decline year-over-year.
  • Tempest Therapeutics, Inc. annual Return On Equity for 2024 was -246%, a 13% increase from 2023.
  • Tempest Therapeutics, Inc. annual Return On Equity for 2023 was -284%, a 117% decline from 2022.
  • Tempest Therapeutics, Inc. annual Return On Equity for 2022 was -131%, a 89% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Tempest Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -311% -123% -66% 01 Jul 2025 30 Sep 2025
Q2 2025 -335% -134% -66% 01 Apr 2025 30 Jun 2025
Q1 2025 -306% -73% -31% 01 Jan 2025 31 Mar 2025
Q4 2024 -246% +38% +13% 01 Oct 2024 31 Dec 2024
Q3 2024 -187% +191% +50% 01 Jul 2024 30 Sep 2024
Q2 2024 -201% +18% +8% 01 Apr 2024 30 Jun 2024
Q1 2024 -232% -79% -51% 01 Jan 2024 31 Mar 2024
Q4 2023 -284% -153% -117% 01 Oct 2023 31 Dec 2023
Q3 2023 -378% -206% -119% 01 Jul 2023 30 Sep 2023
Q2 2023 -219% -68% -46% 01 Apr 2023 30 Jun 2023
Q1 2023 -154% -21% -16% 01 Jan 2023 31 Mar 2023
Q4 2022 -131% -12% -9.8% 01 Oct 2022 31 Dec 2022
Q3 2022 -173% -57% -49% 01 Jul 2022 30 Sep 2022
Q2 2022 -150% -258% -239% 01 Apr 2022 30 Jun 2022
Q1 2022 -132% -221% -249% 01 Jan 2022 31 Mar 2022
Q4 2021 -119% -321% -159% 01 Oct 2021 31 Dec 2021
Q3 2021 -116% +40% +26% 01 Jul 2021 30 Sep 2021
Q2 2021 108% +189% 01 Apr 2021 30 Jun 2021
Q1 2021 89% +175% 01 Jan 2021 31 Mar 2021
Q4 2020 202% +282% 01 Oct 2020 31 Dec 2020
Q3 2020 -156% -84% -118% 01 Jul 2020 30 Sep 2020
Q2 2020 -81% +242% +75% 01 Apr 2020 30 Jun 2020
Q1 2020 -86% -178% -194% 01 Jan 2020 31 Mar 2020
Q4 2019 -80% -112% -350% 01 Oct 2019 31 Dec 2019
Q3 2019 -72% -115% -266% 01 Jul 2019 30 Sep 2019
Q2 2019 -323% 01 Apr 2019 30 Jun 2019
Q1 2019 92% 01 Jan 2019 31 Mar 2019
Q4 2018 32% 01 Oct 2018 31 Dec 2018
Q3 2018 43% 01 Jul 2018 30 Sep 2018

Tempest Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -246% +38% +13% 01 Jan 2024 31 Dec 2024
2023 -284% -153% -117% 01 Jan 2023 31 Dec 2023
2022 -131% -62% -89% 01 Jan 2022 31 Dec 2022
2021 -69% -271% -134% 01 Jan 2021 31 Dec 2021
2020 202% +282% 01 Jan 2020 31 Dec 2020
2019 -80% -112% -350% 01 Jan 2019 31 Dec 2019
2018 32% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.